A randomized, double-blind, placebo-controlled trial (2022) showed that just 2g/day of spirulina for three months significantly reduced HbA1c and fasting blood sugar in type 2 diabetic patients the downstream effects youd expect from enhanced GLP-1 activity
Its a prescription medicine use Captions are provided by our contributors
Overall, our results highlight a possible link between altered incretin responses and WR after RYGB, and support further prospective trials targeting GLP-1/GIP pathways to improve long-term metabolic outcomes
There is no approved titration step at 20mg
Additionally, it promotes overall vitality, which indirectly supports immune health
Like all prescription drugs, taking more than is prescribed is considered an overdose